These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32785853)

  • 1. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications.
    Perucca E; Bialer M
    CNS Drugs; 2020 Aug; 34(8):795-800. PubMed ID: 32504461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
    Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol.
    Feng W; Qin C; Abdelrazig S; Bai Z; Raji M; Darwish R; Chu Y; Ji L; Gray DA; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Int J Pharm; 2022 Aug; 624():121947. PubMed ID: 35753538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal transport as a potential determinant of drug bioavailability.
    Nauli AM; Nauli SM
    Curr Clin Pharmacol; 2013 Aug; 8(3):247-55. PubMed ID: 23343017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development.
    Brocks DR; Davies NM
    J Pharm Pharm Sci; 2018; 21(1s):254s-270s. PubMed ID: 30348249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
    Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C
    Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
    Trevaskis NL; Charman WN; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):702-16. PubMed ID: 18155316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb
    Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.
    Izgelov D; Davidson E; Barasch D; Regev A; Domb AJ; Hoffman A
    Eur J Pharm Biopharm; 2020 Sep; 154():108-115. PubMed ID: 32634571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
    Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
    Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study.
    Devinsky O; Kraft K; Rusch L; Fein M; Leone-Bay A
    J Pharm Sci; 2021 Dec; 110(12):3946-3952. PubMed ID: 34400185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.
    Koch N; Jennotte O; Bourcy Q; Lechanteur A; Deville M; Charlier C; Chiap P; Cardot JM; Evrard B
    Int J Pharm; 2024 May; 657():124173. PubMed ID: 38685441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.
    Khoo SM; Edwards GA; Porter CJ; Charman WN
    J Pharm Sci; 2001 Oct; 90(10):1599-607. PubMed ID: 11745718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
    Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
    J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
    Zhang Z; Gao F; Jiang S; Ma L; Li Y
    Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties.
    Ryšánek P; Grus T; Šíma M; Slanař O
    Pharm Res; 2020 Aug; 37(9):166. PubMed ID: 32770268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.